DEA Investigations of Doctors Explained
A Drug Enforcement Administration (DEA) investigation of a physician usually begins with prescribing data rather than a patient complaint. It can end in an administrative action against your registration, a criminal charge, or both at once. The two tracks often run side by side. Chapman, Dowling & Mallek represents prescribers facing this scrutiny in Detroit and statewide.
What Triggers a DEA Investigation of a Doctor?
The Drug Enforcement Administration opens files from several directions at once. The most common starting points look like this:
- Unusual prescribing patterns
- High opioid prescription volumes
- Large controlled-substance quantities
- Frequent early refill requests
- Prescriptions without clear medical necessity
- Inadequate patient examinations
- Missing or incomplete medical records
- Multiple patients using the same pharmacy
- Patient overdose reports
- Pharmacist or pharmacy complaints
- Prescription Drug Monitoring Program data
- Suspicious cash-pay practices
- Reports from employees or patients
- Prior licensing or compliance problems
None of those triggers amounts to an accusation on its own. Each one is enough to open a file, and files opened this way often sit for months before the prescriber hears anything about them.
How an Administrative Audit Differs From a Criminal Case
An administrative audit reviews compliance with registration, recordkeeping, and dispensing rules and can lead to sanctions affecting your practice. In contrast, a criminal investigation examines whether prescriptions were knowingly issued outside legitimate medical practice.
What Happens When the Case Turns Criminal?
Criminal investigations bring grand jury subpoenas, undercover patients, pharmacy records, and interviews with your former staff. Prosecutors reconstruct the practice patient by patient, usually through a medical reviewer who never met anyone involved.
Nationwide sweeps feed that pipeline. Prescribing cases now appear regularly in coordinated federal enforcement actions alongside billing fraud charges.
Why Does Michigan Prescribing Law Matter Here?
Federal investigators may use violations of Michigan prescribing requirements as evidence in a controlled-substance case. Michigan Compiled Laws § 333.7303a requires a bona fide prescriber-patient relationship before certain controlled substances are prescribed, making weak documentation of that relationship a potential focus of federal scrutiny.
Michigan licensing consequences run on their own schedule. A state disciplinary action can land while the federal case is open, and each proceeding produces statements the other side can use.
Responding to a DEA Investigation
How you handle the first contact significantly impacts what follows. Sound responses share these traits:
- Counsel is retained before any interview, audit, or records production
- Original records are preserved exactly as they exist, with nothing edited
- One person is designated to communicate with investigators
- Staff are told they may speak with agents and may also decline
Diversion investigators may show up unannounced and request immediate access to records. You do not necessarily have to consent to an on-the-spot inspection, and you can remain courteous while requesting that the review be scheduled for a time when counsel can attend.
Defend Your Registration and Your Practice
Your DEA registration determines whether you can prescribe controlled substances, and an order to show cause can place that authority in jeopardy. Chapman, Dowling & Mallek offers free consultations to physicians facing DEA investigations and represents prescribers in cases involving government medical reviewers. Call (346) 242-7626 or contact us online before the response deadline.